Insider trade

Becton Dickinson (BDX): Director sold ~$160K

Bertram L Scott, Director at Becton Dickinson, sold ~$160K of Becton Dickinson shares.

~$160K
Approx. value · 700 sh @ $227.99
36K
Holds after · shares reported
Traded
Feb 12, 2025
Filed
Feb 12, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 19, 2024InsiderOfficer sold ~$634K of BDX shares in the open market
  2. Jan 7, 2025InsiderOfficer sold ~$185K of BDX shares in the open market
  3. Jan 17, 2025InsiderOfficer sold ~$141K of BDX shares in the open market
  4. Jan 21, 2025Insider · 2 peopleInsiders: 2 sales (~$309K)
  5. Feb 10, 2025InsiderDirector purchased ~$350K of BDX shares in the open market
  6. Feb 12, 2025 · this disclosureInsiderDirector sold ~$160K of BDX shares in the open market

What came next

  1. Mar 5, 2025CongressDisclosed sale of BDX — reported range $15,001 - $50,000
  2. Mar 12, 2025InsiderOfficer sold ~$436K of BDX shares in the open market
  3. Mar 18, 2025InsiderOfficer sold ~$106K of BDX shares in the open market
  4. Apr 8, 2025CongressDisclosed sale of BDX — reported range $1,001 - $15,000
  5. Apr 9, 2025InsiderOfficer sold ~$94K of BDX shares in the open market
  6. May 15, 2025CongressDisclosed purchase of BDX — reported range $1,001 - $15,000
  7. May 21, 2025FDARecall: REF: 381434 BD Insyte Autoguard Shielded IV Catheter, 20 GA x 1.16 in (1.1 x 30 mm) 60 mL/min, STERILEEO, RxOnly
  8. May 21, 2025FDARecall: REF: 381923 BD Insyte Autoguard Winged Shielded IV Catheter, 22 GA x 1.00 in (0.9 x 25 mm) 35 mL/min, STERILEEO, RxOnly
  9. May 21, 2025FDARecall: REF: 382544 BD Insyte Autoguard Shielded IV Catheter, 18 GA x 1.16 in (1.3 x 30 mm) 95 mL/min, STERILEEO, RxOnly
  10. May 21, 2025FDARecall: REF: 381433, BD Insyte Autoguard Shielded IV Catheter, 20GA x 1.00 in (1.1x25 mm) 65 mL/min, STERILEEO, RxOnly
  11. May 21, 2025FDARecall: REF: 381423, BD Insyte Autoguard, Shielded IV Catheter, 22GA X 1.00 IN (0.9 X 25 MM) 35mL/min, STERILEEO, RxONLY
  12. May 21, 2025FDARecall: REF: 382944, BD Insyte Autoguard BC Pro Winged Shielded IV Catheter, 18 GA x 1.16 in (1.3 x 30 mm) 95 mL/min, STERILEEO, RxOnly
  13. May 21, 2025FDARecall: REF: 381533, BD Insyte Autoguard Winged, Shielded IV Catheter, 20 GA x 1.00 in (1.1 x 25 mm) 65mL/min, STERILEEO,RxOnly
  14. May 21, 2025FDARecall: REF: 381811, BD Insyte Autoguard BC Pro Winged Shielded IV Catheter, 18 GA x 1.16 in (1.3 x 30 mm) 95 mL/min, STERILEEO, RxOnly
  15. Jun 2, 2025InsiderOfficer sold ~$200K of BDX shares in the open market
  16. Jun 3, 2025FDAFDA device clearance: BD Nexiva™ Diffusics™ Closed IV Catheter System and BD Nexiva™ Diffusics™ Closed IV Catheter System with BD MaxZero™ Needle-free Connector
  17. Jun 3, 2025FDARecall: REF: 666289 , BD FACS, 7-Color Setup Beads, 25 Runs, CE, IVD. Used in flow cytometry for fluorescence compensation.
  18. Jun 3, 2025FDARecall: REF: 123400,Bard Urologist's Tray, For the Obstructed Urethra
  19. Jun 3, 2025FDARecall: BD Heyman Follower Straight Tip for following sizes: 10Fr - REF:21110, 12Fr - REF:21112, 14Fr - REF: 21114, 20Fr - REF: 21120
  20. Jun 3, 2025FDARecall: REF: 335775 , BD FACS, 7-Color Setup Beads, 25 setups per kit, Rx Only, IVD. Used in flow cytometry for fluorescence compensation.
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Becton Dickinson

For Becton Dickinson, OQRO holds 8 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BDX page.

Other recent filings by Bertram L Scott, Director

The full history of Bertram L Scott, Director is on the profile page.

How this filing works

Explore the data

Common questions

Which Becton Dickinson (BDX) insider traded, and how much?

Bertram L Scott, Director at Becton Dickinson, sold ~$160K of Becton Dickinson shares. 700 shares at $227.99.

When did it happen, and when was it made public?

Traded: Feb 12, 2025. Filed: Feb 12, 2025.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Becton Dickinson recently?

For Becton Dickinson, OQRO holds 8 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the BDX page.

Does this mean BDX stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Becton Dickinson

Everything OQRO holds on this company is on its BDX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data